Supira Medical
Tracked across 1 events · 7 articles · First seen Apr 08, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Supira Medical received FDA approval to initiate its SUPPORT II Pivotal Trial and appointed D. Keith Grossman to its Board of Directors, strengthening its position in the percutaneous ventricular assist device (pVAD) market.
Apr 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Supira Medical live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard